JP2002535323A5 - - Google Patents

Download PDF

Info

Publication number
JP2002535323A5
JP2002535323A5 JP2000594799A JP2000594799A JP2002535323A5 JP 2002535323 A5 JP2002535323 A5 JP 2002535323A5 JP 2000594799 A JP2000594799 A JP 2000594799A JP 2000594799 A JP2000594799 A JP 2000594799A JP 2002535323 A5 JP2002535323 A5 JP 2002535323A5
Authority
JP
Japan
Prior art keywords
alkyl
alkenyl
hydroxy
optionally substituted
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000594799A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002535323A (ja
Filing date
Publication date
Priority claimed from GBGB9901236.1A external-priority patent/GB9901236D0/en
Priority claimed from GBGB9923936.0A external-priority patent/GB9923936D0/en
Application filed filed Critical
Priority claimed from PCT/EP2000/000350 external-priority patent/WO2000043383A1/en
Publication of JP2002535323A publication Critical patent/JP2002535323A/ja
Publication of JP2002535323A5 publication Critical patent/JP2002535323A5/ja
Pending legal-status Critical Current

Links

JP2000594799A 1999-01-20 2000-01-17 プロテインキナーゼ阻害剤としてのピペリジニルキノリン Pending JP2002535323A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9901236.1A GB9901236D0 (en) 1999-01-20 1999-01-20 Medicaments
GB9923936.0 1999-10-08
GB9901236.1 1999-10-08
GBGB9923936.0A GB9923936D0 (en) 1999-10-08 1999-10-08 Compounds
PCT/EP2000/000350 WO2000043383A1 (en) 1999-01-20 2000-01-17 Piperidinylquinolines as protein tyrosine kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2002535323A JP2002535323A (ja) 2002-10-22
JP2002535323A5 true JP2002535323A5 (zh) 2007-02-01

Family

ID=26315007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000594799A Pending JP2002535323A (ja) 1999-01-20 2000-01-17 プロテインキナーゼ阻害剤としてのピペリジニルキノリン

Country Status (4)

Country Link
EP (1) EP1144404A1 (zh)
JP (1) JP2002535323A (zh)
AU (1) AU2437900A (zh)
WO (1) WO2000043383A1 (zh)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
FR2798656B1 (fr) * 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
US6403610B1 (en) 1999-09-17 2002-06-11 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
US6803369B1 (en) 2000-07-25 2004-10-12 Smithkline Beecham Corporation Compounds and methods for the treatment of neoplastic disease
PL366335A1 (en) 2000-07-26 2005-01-24 Smithkline Beecham P.L.C. Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
US6603005B2 (en) 2000-11-15 2003-08-05 Aventis Pharma S.A. Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
FR2816618B1 (fr) 2000-11-15 2002-12-27 Aventis Pharma Sa Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
US6602884B2 (en) 2001-03-13 2003-08-05 Aventis Pharma S.A. Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
FR2822154B1 (fr) * 2001-03-13 2005-10-21 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
TW200406410A (en) 2002-01-29 2004-05-01 Glaxo Group Ltd Compounds
AU2003239302A1 (en) 2002-01-29 2003-09-02 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
FR2842807A1 (fr) 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
GB0217294D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844268B1 (fr) 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
US6835841B2 (en) 2002-09-13 2004-12-28 Bristol-Myers Squibb Company Asymmetric catalytic hydrogenation process for preparation of chiral cyclic β-aminoesters
DE60331849D1 (de) 2002-11-05 2010-05-06 Glaxosmithkline Llc Antibakterielle wirkstoffe
EP1567520B1 (en) 2002-12-04 2008-10-15 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
EA200701782A3 (ru) 2003-04-24 2008-04-28 Инсайт Корпорейшн Производные азаспироалканов в качестве ингибиторов металлопротеаз
PT1711181E (pt) 2004-01-23 2009-12-29 Janssen Pharmaceutica Nv Derivados quinolina e sua utilização como inibidores micobacterianos
FR2867472B1 (fr) * 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2872164B1 (fr) * 2004-06-29 2006-11-17 Aventis Pharma Sa Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
ATE466857T1 (de) * 2004-10-05 2010-05-15 Actelion Pharmaceuticals Ltd Neue piperidin-antibiotika
EP1845995A4 (en) 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
US7605169B2 (en) 2005-01-25 2009-10-20 Glaxo Group Limited Antibacterial agents
US7592334B2 (en) 2005-01-25 2009-09-22 Glaxo Group Limited Antibacterial agents
EP1846411A4 (en) 2005-01-25 2010-08-04 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
JP2008528586A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
BRPI0607756A2 (pt) * 2005-02-18 2010-05-18 Astrazeneca Ab composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para inibição de dna girase bacteriana e/ou topoisomerase iv em um animal de sangue quente, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para preparar compostos ou sais farmaceuticamente aceitáveis dos mesmos
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JP2009524643A (ja) 2006-01-26 2009-07-02 アクテリオン ファーマシューティカルズ リミテッド テトラヒドロピラン抗生物質
JP2009532504A (ja) 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌薬
AU2008249745B2 (en) * 2007-05-09 2012-01-12 Pfizer Inc. Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
EP2332939A1 (en) 2009-11-26 2011-06-15 Æterna Zentaris GmbH Novel Naphthyridine derivatives and the use thereof as kinase inhibitors
WO2016138988A1 (en) * 2015-03-02 2016-09-09 University Of Copenhagen Piperazine inhibitors of bacterial gyrase and topoisomerase iv

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721237A (en) * 1991-05-10 1998-02-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
GB9514265D0 (en) * 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
HUP0003364A3 (en) * 1997-06-19 2002-03-28 Sepracor Inc Marlborough Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2717899A (en) * 1998-01-26 1999-08-09 Smithkline Beecham Plc Quinoline derivatives as antibacterials

Similar Documents

Publication Publication Date Title
JP2002535323A5 (zh)
JP2002527434A5 (zh)
JP2002501061A5 (zh)
RU2470022C2 (ru) Оксазолидиновые антибиотики
RU2011127423A (ru) Соединение 2н-хромена и его производное
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
RU2000129161A (ru) Производное 1-[(1-замещенного-4-пиперидинил)метил]-4-пиперидина, способ его получения, фармацевтическая композиция, содержащая указанное соединение, и промежуточный продукт
RU2005132616A (ru) Производные 2-фенокси и 2-фенилсульфонамида с ссr3 антагонистической активностью для лечения астмы и других воспалительных или иммунологических заболеваний
PE20060598A1 (es) Derivado heterociclo conteniendo nitrogeno como antagonista de quimiocina ccr5
CA2557538A1 (en) Benzimidazole derivative and use as an angiotensin ii receptor antagonist
JP2005525324A5 (zh)
CA2475619A1 (en) Piperidine derivatives
JP2008526999A5 (zh)
CA2487542A1 (en) Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
NZ610312A (en) 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
JP2003506406A5 (zh)
RU2005111589A (ru) Производные 1-пиридин-4-илмочевины
RU2006128589A (ru) Стереоизомерные соединения и способы лечения желудочно-кишечных расстройств и расстройств центральной нервной системы
JP2008543781A5 (zh)
RU2008150613A (ru) Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы
JP2005502621A5 (zh)
JP2009501745A5 (zh)
CA2569861A1 (en) Pyrrolidine derivatives as ccr5 antagonists
RU2005105576A (ru) Производные плевромутилина в качестве противомикроюных средств
CA2530140A1 (en) Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof